Clinical effect of Saifurun combined with vitamin B6 in the treatment of patients with hand-foot syndrome caused by Osimertinib
GUO Lianying1 LI Jiuqiang2 WANG Jumei1
1.Department of Oncology, Handan Central Hospital, Hebei Province, Handan 056001, China;
2.Department of Pain, the Third Hospital of Handan, Hebei Province, Handan 056001, China
Abstract Objective To explore the clinical effect of Saifurun combined with vitamin B6 in the treatment of patients with hand-foot syndrome (HFS) caused by Osimertinib. Methods A total of 114 patients with HFS due to oral Osimertinib admitted to Handan Central Hospital of Hebei Province from January 2017 to June 2019 were selected and divided into control group and observation group according to random number table method, with 57 patients in each group. The control group was given vitamin B6 orally, 100 mg/time, three times per day. Based on the control group, the observation group was applied with Saifurun on hands and feet, two to three drops per time, four times per day. During the treatment period, both groups still received oral Osimertinib Mesylate, 80 mg/time, once a day. After six months of treatment, the HFS grading and the improvement rate of quality of life were observed in the two groups, and the quantitative symptom score changes before and after treatment were compared between the two groups. Results After six months of treatment, the HFS grading of the observation group was better than that of the control group, and the difference was statistically significant (P ＜ 0.05). After six months of treatment, the quantitative symptom scores of erythema edema and desiccated skin in both groups were lower than before treatment, and the observation group was lower than the control group, with statistical significance (P ＜ 0.05). The improvement rate of quality of life in the observation group was higher than that in the control group, and the difference was statistically significant (P ＜ 0.05). Conclusion Saifurun combined with vitamin B6, it can improve the symptoms of HFS caused by Osimertinib and improve the quality of life of patients.
GUO Lianying1 LI Jiuqiang2 WANG Jumei1. Clinical effect of Saifurun combined with vitamin B6 in the treatment of patients with hand-foot syndrome caused by Osimertinib[J]. 中国医药导报, 2021, 18(27): 110-112,124.
